Finzati - Logo
VNDA logo

Vanda Pharmaceuticals Inc.

VNDA • Biotechnology
$5.43
▲ +0.09 (+1.69%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$327.03M
Growth
67.5%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Manageable debt level · 0.04Healthy liquidity · 2.39Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:32 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$5.43
Change1.69%
Shares Out60.23M
Market Cap$327.03M
Enterprise Value$157.00M
52W Range4.15 - 9.94
Beta0.60
P/E-1.19
P/S1.52
P/B1.49
P/FCF-1.69
EV/Sales0.73

Investment DNA

How strong this company looks for long-term investors

46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
87/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 2.39Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

VNDA
Analyst sentiment
Based on 19 analyst votes · 2026-09-05
82/100
Bullish
Bullish
13
Hold
5
Bearish
1
Price Target
2026-08-07
Low
$21.00
Mean
$21.00
Median
$21.00
High
$21.00

Company Overview

IPO: 4/12/2006
Industry: Biotechnology
P/B i: 1.49
Debt / Equity i: 0.04
Operating Margin: -69.95%
Net Margin: -102.02%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.04
Current Ratio: 2.39
Quick Ratio: 2.38
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Mitchell Stephen Ray
Transaction: 06/04/2026
BUY
Change
+41,600
Price
Not reported
Filing
06/08/2026
Type
BUY
Honore Tage
Transaction: 06/04/2026
BUY
Change
+41,600
Price
Not reported
Filing
06/08/2026
Type
BUY
Ward Anne Sempowski
Transaction: 06/04/2026
BUY
Change
+41,600
Price
Not reported
Filing
06/08/2026
Type
BUY